Jelena Jeremic
Principal investigator, leads Nostopharma, LLC.
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2022First federal award
$831KFederal grants as PI3 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $831K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 10, 2023 | NIH | SBIR Phase I Small molecules combination therapy using polypharmacology approach as a novel treatment paradigm for rare bone disease | $319K | Nostopharma, LLC |
| Mar 1, 2022 | NSF | STTR Phase I STTR Phase I:Improved drug delivery platforms for localized and sustained drug deposition for traumatic injuries | $256K | Nostopharma, LLC with University of Maryland at Baltimore |
| Feb 18, 2022 | NSF | STTR Phase I STTR Phase I: Improved drug delivery platforms for localized and sustained drug deposition for traumatic injuries | $256K | Nostopharma, LLC |
Peer ranks
Federal funding#1,945
Awards as PI#822
Patents#273
Companies
- Nostopharma, LLCLeads (SEC Form D) · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.